Basel IV output floor leaves corporate SRT ‘scarcely feasible’

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Securitization

Basel IV output floor leaves corporate SRT ‘scarcely feasible’

Bill Thornhill
November 23, 2022 05:55 pm
Basel, Switzerland - November 14, 2022: Life Sciences Cluster Forum at Roche Headquarters with a general View of the Tower Office Buildings. Hoffman-La Roche, Towers, HQ, Headquarter, Zentrale

Significant risk transfers worth €80bn in corporate lending could cease, says Afme

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

EuropeRegulationMarket News
BT
Bill Thornhill

Related articles

Gift this article